$ANTE
AIRNET TECHNOLOGY INC. Stock $ante

$ante Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 20-F Financial Statement

#000110465924052241 Filed on April 26, 2024

Income Statement

Concept	2023 Q4	2023	2022
Revenue	$845.0K	$845.0K	$2.868M
YoY Change	122.37%	-70.54%	-75.44%
Cost Of Revenue	$1.376M	$1.376M	$5.223M
YoY Change	-51.97%	-73.65%	-64.65%
Gross Profit	-$531.0K	-$531.0K	-$2.355M
YoY Change	-78.63%	-77.45%	-23.98%
Gross Profit Margin	-62.84%	-62.84%	-82.11%
Selling, General & Admin	$3.290M	$3.290M	$7.163M
YoY Change	10.4%	-54.07%	-31.85%
% of Gross Profit
Research & Development	$35.00K	$35.00K	$35.00K
YoY Change	105.88%	0.0%	-90.41%
% of Gross Profit
Depreciation & Amortization		$963.0K	$2.836M
YoY Change		-66.04%	-28.28%
% of Gross Profit
Operating Expenses	$3.325M	$3.325M	$11.72M
YoY Change	10.94%	-71.64%	7.8%
Operating Profit	-$3.856M	-$3.856M	-$14.08M
YoY Change	-29.66%	-72.61%	0.75%
Interest Expense	-$206.0K	-$206.0K	-$3.581M
YoY Change	-88.91%	-94.25%	-12.87%
% of Operating Profit
Other Income/Expense, Net	$4.186M	$3.980M	$1.785M
YoY Change	636.97%	122.97%	207.23%
Pretax Income	$124.0K	$124.0K	-$12.29M
YoY Change	-101.1%	-101.01%	-29.76%
Income Tax	$1.000K	$1.000K	$17.00K
% Of Pretax Income	0.81%	0.81%
Net Earnings	-$574.0K	-$574.0K	-$13.34M
YoY Change	-95.04%	-95.7%	-23.07%
Net Earnings / Revenue	-67.93%	-67.93%	-464.96%
Basic Earnings Per Share		-$0.09	-$1.71
Diluted Earnings Per Share	-$0.08	-$0.09	-$1.71
COMMON SHARES
Basic Shares Outstanding		6.571M	7.803M
Diluted Shares Outstanding		6.571M	7.803M

Balance Sheet

Concept	2023 Q4	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$150.0K	$150.0K	$2.700M
YoY Change	-94.44%	-94.44%	21.18%
Cash & Equivalents	$150.0K
Short-Term Investments			$0.00
Other Short-Term Assets	$24.99M	$7.682M	$69.10M
YoY Change	-61.6%	-88.88%	65.82%
Inventory
Prepaid Expenses
Receivables	$19.00K	$19.00K	-$30.20M
Other Receivables	$191.0K	$22.06M	$28.20M
Total Short-Term Assets	$29.92M	$29.92M	$69.80M
YoY Change	-57.14%	-57.14%	90.46%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.24M	$10.24M	$10.90M
YoY Change	-5.93%	-6.05%	-43.58%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$3.848M	$32.02M	$34.10M
YoY Change	-24.3%	-6.11%	-13.79%
Other Assets	$0.00	$0.00	$400.0K
YoY Change	-100.0%	-100.0%	-22.03%
Total Long-Term Assets	$42.26M	$42.26M	$45.30M
YoY Change	-6.83%	-6.71%	-23.72%
TOTAL ASSETS
Total Short-Term Assets	$29.92M	$29.92M	$69.80M
Total Long-Term Assets	$42.26M	$42.26M	$45.30M
Total Assets	$72.17M	$72.17M	$115.1M
YoY Change	-37.32%	-37.29%	19.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.60M	$11.60M	$15.80M
YoY Change	-26.45%	-26.58%	-13.97%
Accrued Expenses	$10.56M	$2.901M	$3.100M
YoY Change	-6.45%	-6.42%	-3.58%
Deferred Revenue	$7.292M
YoY Change	-5.85%
Short-Term Debt	$0.00	$0.00	$12.80M
YoY Change	-100.0%	-100.0%	-15.65%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$84.42M	$84.42M	$101.8M
YoY Change	-17.06%	-17.07%	-3.01%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$8.842M	$8.842M	$0.00
YoY Change	98144.44%		-100.0%
Total Long-Term Liabilities	$8.842M	$8.842M	$0.00
YoY Change	98144.44%		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$84.42M	$84.42M	$101.8M
Total Long-Term Liabilities	$8.842M	$8.842M	$0.00
Total Liabilities	$93.26M	$60.33M	$69.40M
YoY Change	-8.38%	-13.08%	-2.99%
SHAREHOLDERS EQUITY
Retained Earnings	-$318.8M
YoY Change	0.18%
Common Stock	$298.9M
YoY Change	-10.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.85M	$11.85M	$45.80M
YoY Change
Total Liabilities & Shareholders Equity	$72.17M	$72.17M	$115.1M
YoY Change	-37.32%	-37.29%	19.85%

Cashflow Statement

Concept	2023 Q4	2023	2022
OPERATING ACTIVITIES
Net Income	-$574.0K	-$574.0K	-$13.34M
YoY Change	-95.04%	-95.7%	-23.07%
Depreciation, Depletion And Amortization		$963.0K	$2.836M
YoY Change		-66.04%	-28.28%
Cash From Operating Activities		-$1.817M	$614.0K
YoY Change		-395.93%	-112.34%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$0.00	$140.0K
YoY Change		-100.0%
Cash From Investing Activities		$0.00	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$0.00	$0.00
YoY Change			-100.0%
Cash From Financing Activities		-1.222M	1.212M
YoY Change		-200.83%	-112.85%
NET CHANGE
Cash From Operating Activities		-1.817M	614.0K
Cash From Investing Activities		0.000	0.000
Cash From Financing Activities		-1.222M	1.212M
Net Change In Cash		-2.530M	1.131M
YoY Change		-323.7%	-107.85%
FREE CASH FLOW
Cash From Operating Activities		-$1.817M	$614.0K
Capital Expenditures		$0.00	$0.00
Free Cash Flow		-$1.817M	$614.0K
YoY Change		-395.93%	-112.34%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Entity File Number EntityFileNumber	001-33765
CY2023	dei	Entity Registrant Name EntityRegistrantName	AIRNET TECHNOLOGY INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023Q4	us-gaap	Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001413745
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	us-gaap	Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q4	us-gaap	Other Liability Noncurrent Related Party Type Extensible Enumeration OtherLiabilityNoncurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	Suite 301
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Chaoyang District
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Beijing
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	0
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2266000
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1865000
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	100027
CY2023	dei	Entity Address Country EntityAddressCountry	CN
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Firm AuditorFirmId	3487
CY2023	dei	Auditor Name AuditorName	Audit Alliance LLP
CY2023	dei	Auditor Location AuditorLocation	Singapore
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2502000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	150000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1421000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	19000
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	60436000
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	24989000
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	601000
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	191000
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	4834000
CY2023Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	4566000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	69794000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	29915000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10885000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10239000
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	34083000
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	32018000
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	371000
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	0
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2000
CY2022Q4	us-gaap	Assets Assets	115149000
CY2023Q4	us-gaap	Assets Assets	72174000
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	12822000
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	0
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	15774000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	11601000
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	10945000
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	10553000
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	7745000
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	7292000
CY2022Q4	ante	Consideration Received From Buyer Liability ConsiderationReceivedFromBuyerLiability	29000000
CY2023Q4	ante	Consideration Received From Buyer Liability ConsiderationReceivedFromBuyerLiability	28169000
CY2022Q4	ante	Payables Of Earnout Commitment PayablesOfEarnoutCommitment	22120000
CY2023Q4	ante	Payables Of Earnout Commitment PayablesOfEarnoutCommitment	21487000
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1495000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	10000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6000
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1506000
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1550000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	101787000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	84419000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8842000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0
CY2022Q4	us-gaap	Liabilities Liabilities	101796000
CY2023Q4	us-gaap	Liabilities Liabilities	93261000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.04
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.04
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	22500000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	22500000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8948505
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4525643
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8923687
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4474836
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	359000
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	181000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	332746000
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	298750000
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	24818
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	24818
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	1148000
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	1148000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-318239000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-318813000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	32044000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	32879000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	45762000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	11849000
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-32409000
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-32936000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13353000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-21087000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	115149000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	72174000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9192000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2774000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	928000
CY2021	ante	Business Tax And Other Sales Tax BusinessTaxAndOtherSalesTax	119000
CY2022	ante	Business Tax And Other Sales Tax BusinessTaxAndOtherSalesTax	101000
CY2023	ante	Business Tax And Other Sales Tax BusinessTaxAndOtherSalesTax	83000
CY2021	us-gaap	Revenues Revenues	9073000
CY2022	us-gaap	Revenues Revenues	2673000
CY2023	us-gaap	Revenues Revenues	845000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12654000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3114000
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1376000
CY2021	us-gaap	Gross Profit GrossProfit	-3581000
CY2022	us-gaap	Gross Profit GrossProfit	-441000
CY2023	us-gaap	Gross Profit GrossProfit	-531000
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1978000
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1411000
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	559000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7871000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5483000
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2731000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	365000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	35000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	35000
CY2021	us-gaap	Operating Expenses OperatingExpenses	10214000
CY2022	us-gaap	Operating Expenses OperatingExpenses	6929000
CY2023	us-gaap	Operating Expenses OperatingExpenses	3325000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-13795000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-7370000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-3856000
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2884000
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-835000
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-320000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2990000
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2670000
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	114000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	581000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4909000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4186000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5293000
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1404000
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3980000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19088000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5966000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	124000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	284000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-19372000
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-5983000
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	123000
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	1585000
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-6328000
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-317000
CY2021	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	0
CY2022	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	0
CY2023	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	0
CY2021	us-gaap	Profit Loss ProfitLoss	-17787000
CY2022	us-gaap	Profit Loss ProfitLoss	-12311000
CY2023	us-gaap	Profit Loss ProfitLoss	-194000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-452000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1024000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	380000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-17335000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-13335000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-574000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.95
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.95
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.71
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.71
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4390703
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4390703
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7803348
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7803348
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6571281
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6571281
CY2021	us-gaap	Profit Loss ProfitLoss	-17787000
CY2022	us-gaap	Profit Loss ProfitLoss	-12311000
CY2023	us-gaap	Profit Loss ProfitLoss	-194000
CY2020	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	0
CY2021	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	0
CY2022	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	0
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	377000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	359000
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-72000
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-17410000
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-11952000
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-266000
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-452000
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1024000
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-527000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16958000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12976000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	261000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-8934000
CY2022	ante	Stock Issued During Period Value Purchase Of Computer Servers StockIssuedDuringPeriodValuePurchaseOfComputerServers	34179000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	60000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	359000
CY2022	us-gaap	Profit Loss ProfitLoss	-12311000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13353000
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	34179000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5000
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-72000
CY2023	us-gaap	Profit Loss ProfitLoss	-194000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-21087000
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-19372000
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-5983000
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	123000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	258000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	100000
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-119000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1990000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	808000
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	963000
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	571000
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	17000
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	14000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	186000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	60000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	5000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2990000
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2670000
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	114000
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0
CY2021	ante	Cost Of Non Deductible Input Vat Of Prior Years CostOfNonDeductibleInputVatOfPriorYears	521000
CY2022	ante	Cost Of Non Deductible Input Vat Of Prior Years CostOfNonDeductibleInputVatOfPriorYears	27000
CY2023	ante	Cost Of Non Deductible Input Vat Of Prior Years CostOfNonDeductibleInputVatOfPriorYears	132000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7882000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-737000
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1338000
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	628000
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-628000
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	0
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-3375000
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-2422000
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-1136000
CY2021	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	131000
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-142000
CY2023	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-371000
CY2021	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-27000
CY2022	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	0
CY2023	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	0
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3846000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2591000
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4173000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	414000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-457000
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-430000
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	839000
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	4317000
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-453000
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	0
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	76000
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-87000
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	571000
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1098000
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-370000
CY2021	ante	Increase Or Decrease In Operating Lease Liabilities IncreaseOrDecreaseInOperatingLeaseLiabilities	890000
CY2022	ante	Increase Or Decrease In Operating Lease Liabilities IncreaseOrDecreaseInOperatingLeaseLiabilities	17000
CY2023	ante	Increase Or Decrease In Operating Lease Liabilities IncreaseOrDecreaseInOperatingLeaseLiabilities	13000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-5243000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	1858000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1677000
CY2021	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	268000
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1244000
CY2023	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-140000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4975000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	614000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1817000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0
CY2021	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0
CY2022	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0
CY2023	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0
CY2021	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	0
CY2022	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	0
CY2023	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	0
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	0
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	0
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	0
CY2021	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0
CY2022	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0
CY2023	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	18938000
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	10745000
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0
CY2021	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	6762000
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	11942000
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	12822000
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2605000
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0
CY2021	ante	Repayment Of Third Party Debt RepaymentOfThirdPartyDebt	18171000
CY2022	ante	Repayment Of Third Party Debt RepaymentOfThirdPartyDebt	537000
CY2023	ante	Repayment Of Third Party Debt RepaymentOfThirdPartyDebt	0
CY2021	ante	Cash Received From Loan Due To Related Parties CashReceivedFromLoanDueToRelatedParties	0
CY2022	ante	Cash Received From Loan Due To Related Parties CashReceivedFromLoanDueToRelatedParties	1098000
CY2023	ante	Cash Received From Loan Due To Related Parties CashReceivedFromLoanDueToRelatedParties	11600000
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2449000
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0
CY2021	ante	Loans Provided To Related Parties LoansProvidedToRelatedParties	0
CY2022	ante	Loans Provided To Related Parties LoansProvidedToRelatedParties	601000
CY2023	ante	Loans Provided To Related Parties LoansProvidedToRelatedParties	0
CY2021	ante	Cash Repaid For Loan Due To Related Parties CashRepaidForLoanDueToRelatedParties	1531000
CY2022	ante	Cash Repaid For Loan Due To Related Parties CashRepaidForLoanDueToRelatedParties	0
CY2023	ante	Cash Repaid For Loan Due To Related Parties CashRepaidForLoanDueToRelatedParties	0
CY2021	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	698000
CY2022	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0
CY2023	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-9433000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1212000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-1222000
CY2021	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	0
CY2022	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	0
CY2023	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	0
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9433000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1212000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1222000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	367000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-695000
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	509000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-14041000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1131000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2530000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	15610000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1569000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2700000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1569000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2700000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	170000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	268000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	198000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	20000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1301000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2502000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	150000
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	72000
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	12000
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	0
CY2021	us-gaap	Interest Paid Net InterestPaidNet	784000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	838000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	0
CY2021	ante	Share Issuance For Purchase Of Property And Equipment ShareIssuanceForPurchaseOfPropertyAndEquipment	8950000
CY2022	ante	Share Issuance For Purchase Of Property And Equipment ShareIssuanceForPurchaseOfPropertyAndEquipment	34179000
CY2023	ante	Share Issuance For Purchase Of Property And Equipment ShareIssuanceForPurchaseOfPropertyAndEquipment	0
CY2021	ante	Dividend To Settle Payable DividendToSettlePayable	0
CY2022	ante	Dividend To Settle Payable DividendToSettlePayable	0
CY2023	ante	Dividend To Settle Payable DividendToSettlePayable	0
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	94000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1301000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2502000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	150000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1301000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2502000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	150000
CY2023Q4	ante	Negative Working Capital NegativeWorkingCapital	56663000
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 36pt;"><i style="font-style:italic;font-weight:normal;">(d) Use of estimates</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 72pt;">The preparation of financial statements in conformity with US GAAP requires to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period and accompanying notes, including allowance for doubtful accounts, the useful lives of property and equipment, impairment of long-term investments, impairment of long-lived assets, share-based compensation and valuation allowance for deferred tax assets. Actual results could differ from those estimates.</p>
CY2022	us-gaap	Nonmonetary Transaction Gross Operating Revenue Recognized NonmonetaryTransactionGrossOperatingRevenueRecognized	0
CY2023	us-gaap	Nonmonetary Transaction Gross Operating Revenue Recognized NonmonetaryTransactionGrossOperatingRevenueRecognized	0
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10239000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9192000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2774000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	928000
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	7292000
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	5143000
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	5377000
CY2023	ante	Nonmonetary Transaction Direct Costs NonmonetaryTransactionDirectCosts	0
CY2023	ante	Value Added Tax Rate ValueAddedTaxRate	0.06
CY2023	ante	Cost Of Non Deductible Input Vat Of Prior Years CostOfNonDeductibleInputVatOfPriorYears	132000
CY2021	us-gaap	Advertising Expense AdvertisingExpense	143000
CY2022	us-gaap	Advertising Expense AdvertisingExpense	24000
CY2023	us-gaap	Advertising Expense AdvertisingExpense	0
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	4311000
CY2023Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	2972000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2890000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 36pt;"><i style="font-style:italic;font-weight:normal;">(y) Concentration of credit risk</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 72pt;">Financial instruments that potentially expose the Group to concentrations of credit risk consist primarily of cash and accounts receivable. The Group places their cash with financial institutions with high-credit rating and quality in China. For the years ended December 31, 2022 and 2023, there are three and three customers accounting for 10% or more of total revenue, respectively. As of December 31, 2022 and 2023, there are two and one customer accounting for 10% or more of total accounts receivables, respectively.</p>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2953000
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1421000
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	19000
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3797000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3150000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2890000
CY2021	ante	Allowance For Doubtful Accounts Receivable Expenses AllowanceForDoubtfulAccountsReceivableExpenses	234000
CY2022	ante	Allowance For Doubtful Accounts Receivable Expenses AllowanceForDoubtfulAccountsReceivableExpenses	100000
CY2023	ante	Allowance For Doubtful Accounts Receivable Expenses AllowanceForDoubtfulAccountsReceivableExpenses	130000
CY2021	ante	Allowance For Doubtful Accounts Reversed AllowanceForDoubtfulAccountsReversed	-875000
CY2022	ante	Allowance For Doubtful Accounts Reversed AllowanceForDoubtfulAccountsReversed	-380000
CY2023	ante	Allowance For Doubtful Accounts Reversed AllowanceForDoubtfulAccountsReversed	-249000
CY2023	ante	Allowance For Doubtful Accounts Receivable Recoveries Write Offs Net AllowanceForDoubtfulAccountsReceivableRecoveriesWriteOffsNet	265000
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-6000
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	20000
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-83000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3150000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2890000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2953000
CY2022Q4	ante	Other Current Assets Gross OtherCurrentAssetsGross	92007000
CY2022Q4	ante	Other Current Assets Allowance OtherCurrentAssetsAllowance	31571000
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	60436000
CY2023Q4	ante	Other Current Assets Gross OtherCurrentAssetsGross	62451000
CY2023Q4	ante	Other Current Assets Allowance OtherCurrentAssetsAllowance	37462000
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	24989000
CY2022Q4	ante	Loans To Third Parties LoansToThirdParties	6056000
CY2023Q4	ante	Loans To Third Parties LoansToThirdParties	5891000
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.05
CY2023Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.05
CY2020Q4	ante	Stock Issued During Period Shares Purchase Of Computer Servers StockIssuedDuringPeriodSharesPurchaseOfComputerServers	23876308
CY2020Q4	ante	Stock Issued During Period Value Purchase Of Computer Servers StockIssuedDuringPeriodValuePurchaseOfComputerServers	2531000
CY2022Q2	ante	Stock Issued During Period Shares Purchase Of Computer Servers StockIssuedDuringPeriodSharesPurchaseOfComputerServers	179986169
CY2022Q2	ante	Stock Issued During Period Value Purchase Of Computer Servers StockIssuedDuringPeriodValuePurchaseOfComputerServers	34179000
CY2023	ante	Schedule Of Movement Of Allowance For Other Current Assets ScheduleOfMovementOfAllowanceForOtherCurrentAssets	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 5pt 0pt;">Movement of allowance for other current assets is as follows:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:30.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For the years ended December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:justify;margin:0pt;">Beginning of year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"><span style="font-size:10.3pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 57,956</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"><span style="font-size:10.3pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 34,846</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"><span style="font-size:10.3pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 31,571</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:justify;margin:0pt;">Addition</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"><span style="font-size:10.3pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"><span style="font-size:10.3pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"><span style="font-size:10.3pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,788</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:justify;margin:0pt;">Reverse</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"><span style="font-size:10.3pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"><span style="font-size:10.3pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:right;margin:0pt;"> (647)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"><span style="font-size:10.3pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:justify;margin:0pt;">Write off</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"><span style="font-size:10.3pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:right;margin:0pt;"> (24,490)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"><span style="font-size:10.3pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"><span style="font-size:10.3pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:justify;margin:0pt;">Exchange rate adjustment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"><span style="font-size:10.3pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,380</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"><span style="font-size:10.3pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:right;margin:0pt;"> (2,628)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"><span style="font-size:10.3pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:right;margin:0pt;"> (897)</p></td></tr><tr><td style="vertical-align:bottom;width:67.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:justify;margin:0pt;">End of year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"><span style="font-size:10.3pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.24%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 34,846</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"><span style="font-size:10.3pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.24%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 31,571</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;"><span style="font-size:10.3pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.22%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10.3pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 37,462</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p>
CY2020Q4	ante	Other Current Assets Allowance OtherCurrentAssetsAllowance	57956000
CY2021Q4	ante	Other Current Assets Allowance OtherCurrentAssetsAllowance	34846000
CY2022Q4	ante	Other Current Assets Allowance OtherCurrentAssetsAllowance	31571000
CY2023	us-gaap	Additions To Other Assets Amount AdditionsToOtherAssetsAmount	6788000
CY2022	ante	Other Current Assets Reverse OtherCurrentAssetsReverse	-647000
CY2021	ante	Other Current Assets Write Off OtherCurrentAssetsWriteOff	-24490000
CY2021	ante	Other Current Assets Exchange Rate Adjustment OtherCurrentAssetsExchangeRateAdjustment	1380000
CY2022	ante	Other Current Assets Exchange Rate Adjustment OtherCurrentAssetsExchangeRateAdjustment	-2628000
CY2023	ante	Other Current Assets Exchange Rate Adjustment OtherCurrentAssetsExchangeRateAdjustment	-897000
CY2021Q4	ante	Other Current Assets Allowance OtherCurrentAssetsAllowance	34846000
CY2022Q4	ante	Other Current Assets Allowance OtherCurrentAssetsAllowance	31571000
CY2023Q4	ante	Other Current Assets Allowance OtherCurrentAssetsAllowance	37462000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	57864000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49708000
CY2022Q4	ante	Accumulated Impairment Property Plant And Equipment AccumulatedImpairmentPropertyPlantAndEquipment	15110000
CY2023Q4	ante	Accumulated Impairment Property Plant And Equipment AccumulatedImpairmentPropertyPlantAndEquipment	14763000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23923000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	24868000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10885000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10239000
CY2020Q4	ante	Accumulated Impairment Property Plant And Equipment AccumulatedImpairmentPropertyPlantAndEquipment	26262000
CY2021Q4	ante	Accumulated Impairment Property Plant And Equipment AccumulatedImpairmentPropertyPlantAndEquipment	16353000
CY2022Q4	ante	Accumulated Impairment Property Plant And Equipment AccumulatedImpairmentPropertyPlantAndEquipment	15110000
CY2021	ante	Impairment Charges Disposal ImpairmentChargesDisposal	-10537000
CY2021	ante	Impairment Charges Exchange Rate Adjustments ImpairmentChargesExchangeRateAdjustments	628000
CY2022	ante	Impairment Charges Exchange Rate Adjustments ImpairmentChargesExchangeRateAdjustments	-1243000
CY2023	ante	Impairment Charges Exchange Rate Adjustments ImpairmentChargesExchangeRateAdjustments	-347000
CY2021Q4	ante	Accumulated Impairment Property Plant And Equipment AccumulatedImpairmentPropertyPlantAndEquipment	16353000
CY2022Q4	ante	Accumulated Impairment Property Plant And Equipment AccumulatedImpairmentPropertyPlantAndEquipment	15110000
CY2023Q4	ante	Accumulated Impairment Property Plant And Equipment AccumulatedImpairmentPropertyPlantAndEquipment	14763000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3954000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2836000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	963000
CY2021	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	0
CY2022	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	0
CY2023	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	0
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	5083000
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	3848000
CY2022	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	48732000
CY2023	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	47336000
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	29000000
CY2023Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	28170000
CY2019Q4	ante	Supplementary Agreement Outstanding Amount SupplementaryAgreementOutstandingAmount	380000000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2000
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1546000
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	50000
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	43000
CY2022Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	1010000
CY2023Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	994000
CY2022Q4	ante	Deposit Payable Current DepositPayableCurrent	25000
CY2023Q4	ante	Deposit Payable Current DepositPayableCurrent	24000
CY2022Q4	ante	Other Current Liabilities Due To Related Parties OtherCurrentLiabilitiesDueToRelatedParties	7805000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	10000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	19000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	6000
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y2M1D
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	19000
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	6000
CY2022	us-gaap	Lease Cost LeaseCost	19000
CY2023	us-gaap	Lease Cost LeaseCost	6000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	6000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	6000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	6000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1742000
CY2023Q4	ante	Other Current Liabilities Due To Related Parties OtherCurrentLiabilitiesDueToRelatedParties	7634000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	313000
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	311000
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	10945000
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	10553000
CY2023	ante	Assessable Profit To Determine Applicable Tax Rate AssessableProfitToDetermineApplicableTaxRate	2000000.0
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	284000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	17000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2022	ante	Income Tax Expense Benefit Due To Reverse Of Uncertain Tax Provisions IncomeTaxExpenseBenefitDueToReverseOfUncertainTaxProvisions	0
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	284000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19088000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5966000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	124000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4772000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1492000
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	31000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	42000
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	28000
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	15000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	668000
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0
CY2021	ante	Effective Income Tax Rate Reconciliation Unrealized Net Operating Loss EffectiveIncomeTaxRateReconciliationUnrealizedNetOperatingLoss	5971000
CY2022	ante	Effective Income Tax Rate Reconciliation Unrealized Net Operating Loss EffectiveIncomeTaxRateReconciliationUnrealizedNetOperatingLoss	6198000
CY2023	ante	Effective Income Tax Rate Reconciliation Unrealized Net Operating Loss EffectiveIncomeTaxRateReconciliationUnrealizedNetOperatingLoss	-59000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-763000
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-4326000
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	30000
CY2021	ante	Effective Income Tax Rate Reconciliation Effect Of Preferential Tax Rates Granted To Entities EffectiveIncomeTaxRateReconciliationEffectOfPreferentialTaxRatesGrantedToEntities	121000
CY2022	ante	Effective Income Tax Rate Reconciliation Effect Of Preferential Tax Rates Granted To Entities EffectiveIncomeTaxRateReconciliationEffectOfPreferentialTaxRatesGrantedToEntities	0
CY2023	ante	Effective Income Tax Rate Reconciliation Effect Of Preferential Tax Rates Granted To Entities EffectiveIncomeTaxRateReconciliationEffectOfPreferentialTaxRatesGrantedToEntities	0
CY2021	ante	Effect Of Income Tax Rate Change EffectOfIncomeTaxRateChange	-391000
CY2022	ante	Effect Of Income Tax Rate Change EffectOfIncomeTaxRateChange	-1026000
CY2023	ante	Effect Of Income Tax Rate Change EffectOfIncomeTaxRateChange	0
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	76000
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-33000
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-16000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	284000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.015
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.003
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.008
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	10391000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	10104000
CY2022Q4	ante	Deferred Tax Assets Amortization Of Intangible Assets And Concession Fees DeferredTaxAssetsAmortizationOfIntangibleAssetsAndConcessionFees	141000
CY2023Q4	ante	Deferred Tax Assets Amortization Of Intangible Assets And Concession Fees DeferredTaxAssetsAmortizationOfIntangibleAssetsAndConcessionFees	0
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	57172000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	57897000
CY2022	ante	Percentage Of Excess Marketing And Advertising Expense PercentageOfExcessMarketingAndAdvertisingExpense	-0.15
CY2023	ante	Percentage Of Excess Marketing And Advertising Expense PercentageOfExcessMarketingAndAdvertisingExpense	-0.15
CY2022Q4	ante	Deferred Tax Assets Excess Marketing And Advertising Expense DeferredTaxAssetsExcessMarketingAndAdvertisingExpense	28000
CY2023Q4	ante	Deferred Tax Assets Excess Marketing And Advertising Expense DeferredTaxAssetsExcessMarketingAndAdvertisingExpense	0
CY2022Q4	ante	Deferred Tax Assets Impairment On Equipment DeferredTaxAssetsImpairmentOnEquipment	668000
CY2023Q4	ante	Deferred Tax Assets Impairment On Equipment DeferredTaxAssetsImpairmentOnEquipment	3691000
CY2022Q4	ante	Deferred Tax Assets Recognized Cost Of Non Deductible Vat Input Generated In Prior Years DeferredTaxAssetsRecognizedCostOfNonDeductibleVatInputGeneratedInPriorYears	28000
CY2023Q4	ante	Deferred Tax Assets Recognized Cost Of Non Deductible Vat Input Generated In Prior Years DeferredTaxAssetsRecognizedCostOfNonDeductibleVatInputGeneratedInPriorYears	0
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	68427000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	71692000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	68427000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	71692000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	57897000
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	3265000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	68427000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	71692000
CY2018	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	4324000
CY2015	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	2664000
CY2015	ante	Sale Of Equity Interest Percentage SaleOfEquityInterestPercentage	0.75
CY2016	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	1660000
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	11065000
CY2021	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0
CY2022	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0
CY2023	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.04
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17335000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13335000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-574000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4390703
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7803348
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6571281
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.95
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.71
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6540000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.44
CY2022Q4	ante	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue	0.35
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y6M10D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023	ante	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2023	ante	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedWeightedAverageGrantDateFairValue	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2023	ante	Share Based Compensation Arrangement By Share Based Payment Award Options Expired Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredWeightedAverageGrantDateFairValue	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6540000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.44
CY2023Q4	ante	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue	0.35
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y6M10D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	6540000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.44
CY2023Q4	ante	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestWeightedAverageGrantDateFairValue	0.35
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P0Y6M10D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4127672
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.53
CY2023Q4	ante	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue	0.53
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P0Y2M12D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2021	ante	Sharebased Compensation Expense SharebasedCompensationExpense	186000
CY2022	ante	Sharebased Compensation Expense SharebasedCompensationExpense	60000
CY2023	ante	Sharebased Compensation Expense SharebasedCompensationExpense	5000
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2021	ante	Impairment Of Long Term Investments ImpairmentOfLongTermInvestments	0
CY2022	ante	Impairment Of Long Term Investments ImpairmentOfLongTermInvestments	0
CY2023	ante	Impairment Of Long Term Investments ImpairmentOfLongTermInvestments	0
CY2023	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1306486
CY2023	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	17400000
CY2023	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	438137
CY2023Q4	ante	Treasury Stock American Depositary Shares TreasuryStockAmericanDepositaryShares	868349
CY2022	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	769077
CY2023	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	0
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	24818
CY2021	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	1056000
CY2022	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	686000
CY2023	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	319000
CY2023	ante	Description Of General Reserve Limit On Registered Capital DescriptionOfGeneralReserveLimitOnRegisteredCapital	Once the general reserve is accumulated to 50% of the subsidiaries’ registered capital
CY2021	ante	Provisions For Statutory Reserves ProvisionsForStatutoryReserves	0
CY2022	ante	Provisions For Statutory Reserves ProvisionsForStatutoryReserves	0
CY2023	ante	Provisions For Statutory Reserves ProvisionsForStatutoryReserves	0
CY2023Q4	us-gaap	Other Restricted Assets OtherRestrictedAssets	333831000
CY2023Q4	ante	Restricted Assets Paid In Capital Attributable To Variable Interest Entities RestrictedAssetsPaidInCapitalAttributableToVariableInterestEntities	134727000
CY2023Q4	ante	Provision For Statutory Reserves ProvisionForStatutoryReserves	199104000
CY2016Q4	ante	Contingent Liability ContingentLiability	23549000
CY2018	us-gaap	Interest Expense Debt InterestExpenseDebt	7800000

Files In Submission

Name	View Source	Status
0001104659-24-052241-index-headers.html	Edgar Link	pending
0001104659-24-052241-index.html	Edgar Link	pending
0001104659-24-052241.txt	Edgar Link	pending
0001104659-24-052241-xbrl.zip	Edgar Link	pending
ante-20231231.xsd	Edgar Link	pending
ante-20231231x20f.htm	Edgar Link	pending
ante-20231231x20f001.jpg	Edgar Link	pending
ante-20231231xex12d1.htm	Edgar Link	pending
ante-20231231xex12d2.htm	Edgar Link	pending
ante-20231231xex13d1.htm	Edgar Link	pending
ante-20231231xex13d2.htm	Edgar Link	pending
ante-20231231xex15d1.htm	Edgar Link	pending
ante-20231231xex15d2.htm	Edgar Link	pending
ante-20231231xex15d2001.jpg	Edgar Link	pending
ante-20231231xex15d3.htm	Edgar Link	pending
ante-20231231xex15d3001.jpg	Edgar Link	pending
ante-20231231xex4d63.htm	Edgar Link	pending
ante-20231231xex4d64.htm	Edgar Link	pending
ante-20231231xex4d65.htm	Edgar Link	pending
ante-20231231xex4d66.htm	Edgar Link	pending
ante-20231231xex8d1.htm	Edgar Link	pending
ante-20231231xex97d1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
ante-20231231_def.xml	Edgar Link	unprocessable
ante-20231231_lab.xml	Edgar Link	unprocessable
ante-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ante-20231231x20f_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ante-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ANTE
AIRNET TECHNOLOGY INC. Stock $ante

2023 Q4 Form 20-F Financial Statement

#000110465924052241 Filed on April 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ANTE AIRNET TECHNOLOGY INC. Stock $ante

2023 Q4 Form 20-F Financial Statement

#000110465924052241 Filed on April 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ANTE
AIRNET TECHNOLOGY INC. Stock $ante